ROIV
Roivant Sciences Ltd.
$28.56
+0.99%
2026-05-08
About Roivant Sciences Ltd.
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Key Fundamentals
Forward P/E
-24.39
EPS (TTM)
$-1.17
ROE
-19.1%
Revenue Growth (YoY)
-77.8%
Profit Margin
0.0%
Debt/Equity
2.19
Price/Book
4.70
Beta
1.14
Market Cap
$20.23B
Avg Volume (10D)
4.6M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$30.33
60D Low
$25.95
Avg Volume
5.2M
Latest Close
$28.56
Get breakout alerts for ROIV
Sign up for Breakout Scanner to receive daily notifications when ROIV triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Roivant Sciences Ltd. (ROIV) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors ROIV daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ROIV operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.